Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$56.44 - $118.81 $237,048 - $499,002
4,200 New
4,200 $252,000
Q3 2021

Nov 12, 2021

SELL
$116.17 - $194.55 $151,021 - $252,915
-1,300 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$130.4 - $225.58 $365,120 - $631,624
-2,800 Reduced 68.29%
1,300 $288,000
Q1 2021

May 17, 2021

SELL
$124.11 - $190.17 $124,110 - $190,170
-1,000 Reduced 19.61%
4,100 $542,000
Q4 2020

Feb 12, 2021

BUY
$112.16 - $174.14 $572,016 - $888,113
5,100 New
5,100 $883,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.01B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Andra Ap Fonden Portfolio

Follow Andra Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.